California Life Sciences is amplifying the innovative work being done by our member companies.
Mispro to Expand Contract Vivarium Network to Palo Alto
By California Life Sciences Member: Mispro
Palo Alto, CA – Innovative contract vivarium organization, Mispro, plans to expand its vivarium research labs network to Palo Alto’s prestigious Stanford Research Park. The new facility, set to open its doors in October 2023, Read more here!
Neurocrine Biosciences Supports the Mental Health Community During Tardive Dyskinesia Awareness Week
By California Life Sciences Member: Neurocrine Biosciences
SAN DIEGO, May 1, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its continued support of increasing awareness regarding the prevalence, impact and importance of screening for tardive dyskinesia (TD), during Tardive Dyskinesia Awareness Week, May 1-7. Read more here!
eBook: The Ultimate Guide to Clinical Data Management
By California Life Sciences Member: IDDI
April 27, 2023 — Ensuring clinical data is ready for regulatory submission. This eBook is a must-read that will enable clinical professionals to better understand the Clinical Data Management (CDM) processes involved in a clinical trial to ensure clinical data is ready for submission. Read more here!
GeminiBio Opens New cGMP Bioprocess Liquid Manufacturing Facility
By California Life Sciences Member: Gemini Bio
March 28, 2023 — Gemini Bioproducts, LLC (“GeminiBio”), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids for the biotech industry and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Ft. Lauderdale, Florida based healthcare private equity firm, today announced the opening of a new, state‐of‐the‐art cGMP bioprocess liquid manufacturing facility in West Sacramento, California. Read more here!
Center for Breakthrough Medicines, Nucleus Biologics, and Stoic Bio Announce Strategic Collaboration for Steady Supply of Quality Controlled Cell Culture Media to Expedite Development of Cell and Gene Therapies
By California Life Sciences Member: Nucleus Biologics
March 7, 2023 — In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, have announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), Read more here!
Providing the necessary professional and networking resources to help our members stay connected.
BIO International ConventionJune 5 @ 8:00 am - June 8 @ 5:00 pm
RESI BostonJune 5 @ 8:00 am - June 7 @ 5:00 pm
Australian Women in Life Sciences Leadership – A Global PerspectiveJune 5 @ 11:30 am - 1:30 pm
SF Business Times: The Business of PrideJune 8 @ 5:30 pm - 8:30 pm
California Life Sciences FAST Advisory Program – Overview and How to ApplyJune 13 @ 11:00 am - 12:30 pm
BisNow: Bay Area Life Sciences ConferenceJune 27 @ 8:00 am - 5:00 pm